
Cradle is an AI-powered protein engineering platform that accelerates the discovery and optimization of proteins. Their platform allows scientists to generate protein candidates, explore experimental data, and manage protein design projects. Cradle is trusted by leading scientific teams at companies like Novo Nordisk, Johnson & Johnson, and IFF. They offer a SaaS subscription model with different licensing tiers (Standard, Enterprise, Academic) that include unlimited users, data storage, and expert support, while ensuring full ownership of intellectual property. The company's approach leverages machine learning models that learn from wet lab data to improve protein properties such as activity, binding, stability, and expression, leading to faster development timelines (reported 1.5-12x faster) and enabling breakthroughs in therapeutics, agricultural solutions, and food ingredients. Cradle is SOC 2 compliant and emphasizes data privacy and security.

Cradle is an AI-powered protein engineering platform that accelerates the discovery and optimization of proteins. Their platform allows scientists to generate protein candidates, explore experimental data, and manage protein design projects. Cradle is trusted by leading scientific teams at companies like Novo Nordisk, Johnson & Johnson, and IFF. They offer a SaaS subscription model with different licensing tiers (Standard, Enterprise, Academic) that include unlimited users, data storage, and expert support, while ensuring full ownership of intellectual property. The company's approach leverages machine learning models that learn from wet lab data to improve protein properties such as activity, binding, stability, and expression, leading to faster development timelines (reported 1.5-12x faster) and enabling breakthroughs in therapeutics, agricultural solutions, and food ingredients. Cradle is SOC 2 compliant and emphasizes data privacy and security.
What they do: AI-powered SaaS platform for protein design and optimization
Customers: Enterprise life-science and industrial customers (examples: Novo Nordisk, Johnson & Johnson, IFF)
Wet lab: Operates an internal wet lab in Amsterdam for model validation and dataset generation
Recent funding: $73M Series B (Nov 2024); prior $24M Series A (Nov 2023)
Protein engineering and discovery for therapeutics, industrial enzymes, vaccines, peptides, food ingredients and agricultural solutions
2021
Biotechnology
Earlier seed round referenced (~$5.5M) in reporting
24000000 USD
73000000 USD
Participation from Index Ventures and Kindred Capital
“Backed by venture investors including IVP, Index Ventures and Kindred Capital; additional individual/angel investors listed”
| Company |
|---|